225 related articles for article (PubMed ID: 19379520)
1. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study.
Sarfati D; Hill S; Blakely T; Robson B; Purdie G; Dennett E; Cormack D; Dew K
BMC Cancer; 2009 Apr; 9():116. PubMed ID: 19379520
[TBL] [Abstract][Full Text] [Related]
2. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
[TBL] [Abstract][Full Text] [Related]
3. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
[TBL] [Abstract][Full Text] [Related]
5. Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer.
Hanna N; Bikov KA; McNally D; Onwudiwe NC; Dalal M; Mullins CD
Oncologist; 2012; 17(9):1191-7. PubMed ID: 22767876
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
7. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
[TBL] [Abstract][Full Text] [Related]
8. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity among patients with colon cancer in New Zealand.
Sarfati D; Tan L; Blakely T; Pearce N
N Z Med J; 2011 Jul; 124(1338):76-88. PubMed ID: 21946965
[TBL] [Abstract][Full Text] [Related]
10. Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
Ortiz-Ortiz KJ; Tortolero-Luna G; Ríos-Motta R; Veintidós-Feliú A; Hunter-Mellado R; Torres-Cintrón CR; Suárez-Ramos T; Magno P
PLoS One; 2018; 13(3):e0194415. PubMed ID: 29584752
[TBL] [Abstract][Full Text] [Related]
11. A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes.
Sarfati D; Gurney J; Stanley J; Koea J
BMC Cancer; 2014 Nov; 14():821. PubMed ID: 25380581
[TBL] [Abstract][Full Text] [Related]
12. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
13. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
14. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
[TBL] [Abstract][Full Text] [Related]
15. Trends in Adjuvant Chemotherapy Use Among Stage III Colon Cancer in Non-Elderly and Low Comorbidity Patients.
El Hajj J; Soleja M; Goksu SY; Ahn C; Sanford NN; Karagkounis G; Pogacnik JS; Ali F; Chilakamarry S; Kainthla R; Hsiehchen D; Jones AL; Al Mutar S; Sanjeevaiah A; Beg MS; Huang EH; Kazmi SM
Clin Colorectal Cancer; 2022 Dec; 21(4):315-324. PubMed ID: 36283915
[TBL] [Abstract][Full Text] [Related]
16. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
Schrag D; Cramer LD; Bach PB; Begg CB
J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
[TBL] [Abstract][Full Text] [Related]
17. Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.
Hines RB; Chatla C; Bumpers HL; Waterbor JW; McGwin G; Funkhouser E; Coffey CS; Posey J; Manne U
J Clin Oncol; 2009 Sep; 27(26):4339-45. PubMed ID: 19652054
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy in stage 1 colon cancer: Patient characteristics and survival analysis from the national cancer database.
Hsu AT; Wolf JH; D'Adamo CR; Felton J; Paul S; Kumar P; Mavanur AA
Surg Oncol; 2024 Jun; 54():102075. PubMed ID: 38636304
[TBL] [Abstract][Full Text] [Related]
19. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis.
Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM
J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156
[TBL] [Abstract][Full Text] [Related]
20. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
